(TheNewswire)
London, Ontario - TheNewswire – December 16, 2020 -Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) continues to gainattention this week as the company shares have reached new levels overthe past few days. Dr. Philip Toleikis, President and CEO of Sernovawas interviewed earlier this week by Pat Beechinor ofMarketRadio.com.
With the continued valuation of it’s Cell PouchSystem in the ongoing clinical trial at the University of Chicago,Sernova has positioned itself as a leader in the cell and gene therapyfield has continues to garner attention from key players in theindustry with continued ongoing discussions with pharmapartners.
Click URL below to Play Interview
The hope for a cure
Sernova's Cell Pouch System TM delivers thepromise of a functional cure for Type 1 Diabetes (T1D) – in the home city (London, ON) of Banting House , where 100 years ago, Dr. Frederick Banting begin its work on whathas been to date one of the biggest breakthrough in medicine: Insulin.
A century later, Sernova’s Cell Pouch System could revolutionize the currentstandard of care with its therapeutic solution made of a device,smaller than a business card, and placed deep under a patient's skinto serve as a natural environment for therapeutic cells and allow forthe body to regain its ability to produce needed proteins orhormones.
Sernova’s clinical investigator, Dr. Piotr Witkowskihas been invited to share recent developments at the American Society of Transplant Surgeons21 st Annual State of the Art WinterSymposium were he will present to morethan 600 transplant professionals on January 15, 2021.
For further details and media inquiries, pleasecontact:
Mr. Dominic Gray
Sernova Corp
Tel: (519) 858-5126
dominic.gray@sernova.com
Forward-Looking Information
This release and associated Podcast may contain forward-looking statements.Forward-looking statements are statements that are not historicalfacts and are generally, but not always, identified by the words“expects”, “plans”, “anticipates”, “believes”,“intends”, “estimates”, “projects”, “potential” andsimilar expressions, or that events or conditions “will”,“would”, “may”, “could” or “should” occur. AlthoughTheNewswire believes the expectations expressed in suchforward-looking statements are based on reasonable assumptions, suchstatements are not guarantees of future performance and actual resultsmay differ materially from those in forward-looking statements.Forward-looking statements, are based on the beliefs, estimates andopinions on the date such statements were made. TheNewswire expresslydisclaims any intention or obligation to update or revise anyforward-looking statements whether as a result of new information,future events or otherwise.
Copyright (c) 2020 TheNewswire - All rightsreserved.
Copyright (c) 2020 TheNewswire - All rights reserved.